Jci_page_head_homepage_01 Jci_page_head_homepage_02
Heng-Fu Bu, Xiu-Li Zuo, Xiao Wang, Michael A. Ensslin, Vjola Koti, Wei Hsueh, Adam S. Raymond, Barry D. Shur, Xiao-Di Tan
Published in Volume 117, Issue 12
J Clin Invest. 2007; 117(12):3673–3683 doi:10.1172/JCI31841
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 9
MFG-E8 is essential for maintenance of intestinal mucosal homeostasis and integrity in septic mice.

(AC) Treatment with recombinant MFG-E8 restores enterocyte crypt-villus migration in septic mice. (A) Experimental protocol. MFG-E8 (2 mg/kg, i.p.) and BrdU (50 mg/kg, i.p.) were given to mice at the times indicated. After sacrificing the animals, small intestinal tissues were processed for immunostaining. (B) MFG-E8 restored intestinal epithelial cell migration along crypt-to-villus axis in septic mice. Scale bars: 150 μm. (C) Increase in BrdU-labeled enterocyte crypt-villus migration after treatment with MFG-E8, as revealed by quantitative analysis. n = 7. **P < 0.01 versus CLP + BSA group. (D) Endogenous MFG-E8 is required for intestinal repair after septic challenge. Wild-type and MFG-E8–knockout mice were subjected to sublethal CLP and sacrificed 4 days later. Small intestinal tissues were processed for routine histology. H&E stain. The inset shows mucosal injury in a selected area at higher magnification. Scale bars: 150 μm; 75 μm (inset).